Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Baxter
Express Scripts
McKesson
AstraZeneca

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Emcure Pharms Ltd Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for EMCURE PHARMS LTD, and what generic and branded alternatives to EMCURE PHARMS LTD drugs are available?

EMCURE PHARMS LTD has twenty-nine approved drugs.

There is one tentative approval on EMCURE PHARMS LTD drugs.

Summary for Emcure Pharms Ltd
US Patents:0
Tradenames:26
Ingredients:26
NDAs:29

Drugs and US Patents for Emcure Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emcure Pharms Ltd FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 079025-002 Sep 17, 2010 AB RX No Yes   Start Trial   Start Trial
Emcure Pharms Ltd ADENOSINE adenosine SOLUTION;INTRAVENOUS 202313-002 Sep 15, 2014 DISCN No No   Start Trial   Start Trial
Emcure Pharms Ltd ZOLEDRONIC ACID zoledronic acid INJECTABLE;INTRAVENOUS 201783-001 Mar 12, 2013 AP RX No No   Start Trial   Start Trial
Emcure Pharms Ltd ZOLEDRONIC ACID zoledronic acid INJECTABLE;INTRAVENOUS 201801-001 Mar 29, 2013 AP RX No No   Start Trial   Start Trial
Emcure Pharms Ltd LEVOFLOXACIN levofloxacin INJECTABLE;INJECTION 202590-002 Jan 24, 2013 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Medtronic
AstraZeneca
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.